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Tenofovir (TFV) in the form of ester prodrug tenofovir disoproxil fumarate (TDF) is an 
essential part of combination antiretroviral therapy. It is often used in the prevention of 
perinatal HIV transmission. However, precise mechanism(s) involved in transfer of 
TFV/TDF from mother to fetus are not described in detail. Since these drugs are 
nucleoside analogues, there is a possibility that the mechanisms of their transplacental 
passage might include nucleoside transporters (NTs), either equilibrative or concentrative 
(ENTs/CNTs). 
The aim of the diploma thesis was to investigate the role of placental NTs in membrane 
transfer of TFV and TDF. To address this issue, we performed in vitro accumulation in 
the BeWo cell line derived from placental choriocarcinoma.  
By evaluating experiments, we found out that both TFV and TDF might not be substrates 
of NTs, thus the role of these transporters in TFV/TDF placental pharmacokinetics was 
not confirmed. Therefore, the drug-drug interactions on NTs are not expected as well as 
a significant effect of potential variable expression of NTs on transplacental 
pharmacokinetics of the mentioned drug and its prodrug.  
 
